Key Events This Week
10 Aug: Downgrade to Strong Sell rating announced
11 Aug: Technical momentum shifts to bearish; stock closes at ₹402.70 (-0.30%)
13 Aug: Intraday recovery with 3.5% gain to ₹414.05
14 Aug: Mixed technical signals with daily moving averages turning mildly bullish

Panacea Biotec Ltd Shows Signs of Technical Momentum Shift Amid Mixed Indicator Signals
2026-08-14 08:03:05Panacea Biotec Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish trend. Despite a recent upgrade in its Mojo Grade from Strong Sell to Sell, the stock’s price action and technical indicators reveal a complex picture that investors should carefully analyse before making decisions.
Read full news article
Panacea Biotec Ltd Downgraded to Strong Sell Amid Technical and Fundamental Weaknesses
2026-08-11 08:49:01Panacea Biotec Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 10 August 2026, driven primarily by deteriorating technical indicators, stagnant financial performance, and weak fundamental metrics. The pharmaceutical company’s Mojo Score has declined to 17.0, reflecting growing concerns over its valuation, financial trends, and market positioning amid a challenging sector environment.
Read full news article
Panacea Biotec Ltd Faces Technical Momentum Shift Amid Bearish Signals
2026-08-11 08:04:36Panacea Biotec Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish stance. This change is underscored by a combination of technical indicators including MACD, RSI, Bollinger Bands, and moving averages, signalling a cautious outlook for investors amid recent price declines and sector volatility.
Read full news articlePanacea Biotec Ltd Declines 1.90% Amid Mixed Technical Signals and Market Volatility
2026-08-08 16:15:26
Key Events This Week
3 Aug: Technical momentum shifts to sideways with cautious outlook
4 Aug: Mojo Grade upgraded to Sell on technical improvements despite weak fundamentals
5 Aug: Technical momentum shifts back to sideways trend amid mixed indicators
6 Aug: Stock price declines amid bearish weekly MACD and RSI signals
7 Aug: Mildly bullish daily moving averages signal potential short-term momentum

Panacea Biotec Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-08-07 08:03:19Panacea Biotec Ltd has exhibited a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance, despite a complex array of mixed signals from key technical indicators. The stock’s recent performance and technical parameters suggest cautious optimism amid ongoing volatility in the Pharmaceuticals & Biotechnology sector.
Read full news articlePanacea Biotec Limited - Updates
18-Nov-2019 | Source : NSEPanacea Biotec Limited has informed the Exchange regarding 'Compliance under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding publication of Extract of Statement of Unaudited Financial Results for the quarter and half year ended 30.09.2019'.
Panacea Biotec Limited - Outcome of Board Meeting
15-Nov-2019 | Source : NSEPanacea Biotec Limited has informed the Exchange regarding Board meeting held on November 14, 2019.
Panacea Biotec Limited - Updates
08-Nov-2019 | Source : NSEPanacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during October, 2019 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018'.
Corporate Actions
No Upcoming Board Meetings
Panacea Biotec Ltd has declared 75% dividend, ex-date: 19 Sep 11
No Splits history available
No Bonus history available
No Rights history available









